A recent study conducted at the University of Michigan Health System found that a blood test can detect the recurrence of oropharyngeal cancer. Oropharyngeal cancer occurs in throat, tonsils and back of the tongue. It is often connected to the human papilloma virus (HPV), which usually makes the cancer more responsive to treatment. However, in about 15 to 20 percent of patients, the cancer returns because the treatment failed, which cannot be detected through biomarkers.
To read the full article click here.